IASR Vol.17 No.3 March 1996 (No.193)
–³‹Û�«�‘–Œ‰Š‚ÆŠÖ˜AƒEƒCƒ‹ƒX‚Ì“®Œü�@1995
–ÚŽŸ
- ƒGƒR�[ƒEƒCƒ‹ƒX‚VŒ^‚Ì—¬�s�F’¹ŽæŒ§
- 1995”N‚̃€ƒ“ƒvƒXƒEƒCƒ‹ƒXŒŸ�o�ó‹µ�F�H“cŒ§
- AŒ^ŠÌ‰Š‚Ì�W’c”�¶�F�ç—tŽs
- fluoroquinolone‘Ï�«�Ô—Ÿ�‘“à—á
- HIVŠ´�õ�ó‹µ�i1995”N––Œ»�Ý�j�F“ú–{
- ŒŒ‰t�»�܂ɂæ‚éAŒ^ŠÌ‰Š�F•Ä�‘
- гŽÒ‚Æ‹ŸŒŒŽÒ‚ÌHCV‚̈â“`ŽqŒ^�FƒJƒiƒ_
- –ƒ�]�E•—�]�F‰p�‘
- �¬Ž™‚̃�ƒNƒ`ƒ“�ÚŽí—¦�F•Ä�‘
- —\–h�ÚŽíƒXƒPƒWƒ…�[ƒ‹�Fƒˆ�[ƒ�ƒbƒp
- ’j�«–ò•¨�í’�ŽÒ‚ÌHIVŠ´�õƒŠƒXƒN�sˆ×�F•Ä�‘
- Œ‹Šj‚ÆAIDS“¯Žžœëг—¦�F•Ä�‘
- �‘–Œ‰Š‹Û�«�‘–Œ‰Š�F‰p�‘
- “Å‘f”ñŽY�¶�«ƒWƒtƒeƒŠƒA‹ÛŠ´�õ�F‰p�‘
Return to the IASR HomePage
Return to the IASR HomePage(English)

ƒz�[ƒ€‚Ö–ß‚é